Table 3 Questionnaire outcomes summarised by pathology group, excluding those reporting rheumatoid arthritis (n = 690)
Bursitis (limited inflammation) (n = 291) | Bursitis (extensive inflammation) (n = 177) | RC tear (n = 122) | Limited pathology (n = 100) | |
|---|---|---|---|---|
Percentage of sample | 40% | 39% | 33% | 42% |
Age, years, mean (SD) | 49.9 (11.1) | 64.8 (9.2) | 67.1 (10.4) | 47.5 (12.6) |
Female sex, % | 63 | 45 | 47 | 55 |
Smoker, % | 40 | 39 | 33 | 42 |
Comorbidity count, median (IQR) | 1 (0–2) | 2 (1–2) | 2 (1–3) | 1 (0–2) |
Painful sites count (including target), median (IQR) | 3 (1–6) | 3 (1–7) | 3 (1–6) | 2 (1–4) |
Follow-up, months, median (IQR) | 26 (23–29) | 26 (22–29) | 25 (23–29) | 24 (21–26) |
Had shoulder fracture before scan, % | 2 | 2 | <1 | 1 |
Had shoulder dislocation before scan, % | 1 | – | 4 | 1 |
Had breast/shoulder cancer before scan, % | <1 | – | – | – |
Had major injury to target shoulder before scan, % | 7 | 8 | 18 | 3 |
Had shoulder fracture since scan, % | <1 | 1 | – | 1 |
Had shoulder dislocation since scan, % | <1 | – | – | – |
Had breast/shoulder cancer since scan, % | <1 | <1 | – | – |
Had major injury to target shoulder since scan, % | 1 | 2 | 7 | 1 |
Had physiotherapy since scan, % | 65 | 62 | 59 | 58 |
Had injection since scan, % | 76 | 67 | 48 | 61 |
Had more than one injection since scan, % | 33 | 30 | 22 | 24 |
Had surgery since scan, % | 23 | 21 | 28 | 16 |
Still has shoulder pain, % | 63 | 63 | 77 | 64 |
If still in pain | ||||
Pain duration, months, median (IQR) | 24 (12–36) | 21 (12–36) | 25 (12–36) | 24 (18–36) |
Has pain-free periods, % | 70 | 77 | 72 | 77 |
Experiences pain on moving in a certain way, % | 91 | 93 | 92 | 85 |
If not still in pain | ||||
How long since last had pain, months, median (IQR) | 12 (6–17) | 13 (12–20) | 12 (6–18) | 12 (10–20) |
How long did pain last, months, median (IQR) | 9 (3–15) | 9 (5–18) | 12 (12–18) | 6 (4–12) |
Symptoms at time of questionnaire | ||||
SPADI pain, median (IQR) | 34 (4–62) | 26 (2–62) | 48 (18–66) | 32 (6–64) |
SPADI difficulty, median (IQR) | 13 (0–45) | 14 (0–43) | 30 (10–54) | 9 (0–38) |
SPADI total, median (IQR) | 24 (3–52) | 21 (3–51) | 41 (15–59) | 25 (5–49) |
Shoulder activity score, median (IQR) | 6 (3–10) | 6 (3–10) | 5 (3–9) | 7 (4–11) |
EQ-5D health index score, median (IQR) | 0.8 (0.6–0.8) | 0.7 (0.6–0.8) | 0.7 (0.5–0.8) | 0.8 (0.7–0.8) |
EQ-5D VAS, median (IQR) | 80 (55–90) | 80 (60–90) | 75 (60–80) | 80 (70–90) |
EQ-5D anxiety or depression (>0), % | 34 | 30 | 40 | 29 |
Depression reported in comorbidity list, % | 17 | 14 | 18 | 14 |
Difficulty standing from sitting (>1), % | 16 | 20 | 21 | 10 |